Magnetic Resonance Imaging (MRI) Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis - Results of a Phase II Study

被引：0
|
作者：
Sorensen, Per
Drulovic, Jelena
Havrdova, Eva
Lisby, Steen
Derosier, Frederick
Shackelford, Steve
Filippi, Massimo
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A85 / A85
页数：1
相关论文
共 50 条
  • [21] Magnetic resonance imaging findings of a phase III trial comparing Betaferon® with Copaxone® treatments in relapsing-remitting multiple sclerosis
    Filippi, M.
    Arnason, B. G. W.
    Comi, G.
    Cook, S.
    Goodin, D.
    Hartung, H-P.
    Jeffery, D.
    Kappos, L.
    O'Connor, P.
    Bogumil, T.
    Stemper, B.
    Filipov, V.
    Groth, M.
    Boateng, F.
    JOURNAL OF NEUROLOGY, 2008, 255 : 9 - 10
  • [22] A phase II study of neuroprotective agent riluzole in early relapsing-remitting multiple sclerosis
    Waubant, Emmanuelle
    Julian, Laura
    Okuda, Darin
    Green, Ari
    Chabas, Dorothee
    Kornyeyeva, Elena
    Bissonnette, Daniel
    Mowry, Ellen M.
    Pelletier, Daniel
    MULTIPLE SCLEROSIS, 2008, 14 : S184 - S184
  • [23] Phase II study for the treatment of relapsing-remitting multiple sclerosis patients with biomoduline T
    Lorenzo Antonio, Gamez Morales
    Lara Rodriguez Rosa, F.
    Martin Roman, Rodriguez
    Monteagudo Alina, Gonzalez-Quevedo
    Carriera Rebeca, Fernandez
    Silva Natalia, Marzoa
    REVISTA MEXICANA DE NEUROCIENCIA, 2007, 8 (01): : 28 - 31
  • [24] MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis
    R. Zivadinov
    R. De Masi
    D. Nasuelli
    L. Monti Bragadin
    M. Ukmar
    R. S. Pozzi-Mucelli
    A. Grop
    G. Cazzato
    M. Zorzon
    Neuroradiology, 2001, 43 : 272 - 278
  • [25] THE EFFICACY OF AZATHIOPRINE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS
    GOODKIN, DE
    BAILLY, RC
    TEETZEN, ML
    HERTSGAARD, D
    BEATTY, WW
    NEUROLOGY, 1991, 41 (01) : 20 - 25
  • [26] MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis
    Zivadinov, R
    De Masi, R
    Nasuelli, D
    Bragadin, LM
    Ukmar, M
    Pozzi-Mucelli, RS
    Grop, A
    Cazzato, E
    Zorzon, M
    NEURORADIOLOGY, 2001, 43 (04) : 272 - 278
  • [27] ASSESSMENT OF ACTIVITY OF THE INDIVIDUAL LESIONS IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS ON MAGNETIC-RESONANCE-IMAGING
    ZHAO, GJ
    LI, DKB
    TANTON, BL
    PATY, DW
    ANNALS OF NEUROLOGY, 1991, 30 (02) : 270 - 270
  • [28] Effects of BG-12 on Magnetic Resonance Imaging (MRI) Endpoints in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Data From the Phase 3 CONFIRM Study
    Miller, David
    Fox, Robert
    Phillips, J. Theodore
    Kita, Mariko
    Hutchinson, Michael
    Havrdova, Eva
    Zhang, Ray
    Viglietta, Vissia
    Dawson, Katherine
    NEUROLOGY, 2012, 78
  • [29] Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis - Results of a longitudinal magnetic resonance spectroscopy study
    De Stefano, N
    Matthews, PM
    Fu, LQ
    Narayanan, S
    Stanley, J
    Francis, GS
    Antel, JP
    Arnold, DL
    BRAIN, 1998, 121 : 1469 - 1477
  • [30] Magnetic resonance imaging (MRI) outcomes in patients with relapsing-remitting multiple sclerosis (RRMS) treated with cladribine tablets: results from the 120-week Phase IIIb extension of the CLARITY study
    Comi, G.
    Giovannoni, G.
    Cook, S.
    Rieckmann, P.
    Rammohan, K.
    Soelberg-Sorensen, P.
    Vermersch, P.
    Martin, E.
    Dangond, F.
    SWISS MEDICAL WEEKLY, 2016, 146 : 77S - 77S
12345